Showing results (2111-2120 of 2,910) with videos related to
Sort By:
Pageof 291
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 13, 2019
Depomedroxyprogesterone acetate therapy for hot flashes in survivors of breast cancer: no unfavorable impact on recurrence and survivalNatalie M Ertz-Archambault, Lana B Rogoff, Heidi E Kosiorek, et al.Journal of Clinical Pathology|March 1, 1995
Internal quality assurance in a clinical virology laboratory. II. Internal quality controlJ J Gray, T G Wreghitt, T A McKee, et al.The British Journal of General Practice : the Journal of the Royal College of General Practitioners|October 1, 2014
Predicted 10-year risk of cardiovascular disease is influenced by the risk equation adopted: a cross-sectional analysisBenjamin J Gray, Richard M Bracken, Daniel Turner, et al.Gynecologic Oncology|January 21, 2018
Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignanciesHeidi J Gray, Katherine Bell-McGuinn, Gini F Fleming, et al.Annals of Surgical Oncology|September 21, 2010
Triple-negative breast cancers: unique clinical presentations and outcomesJulie A Y Billar, Amylou C Dueck, Chee-Chee H Stucky, et al.The Journal of Infectious Diseases|December 1, 1991
Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations, and response to treatmentR L Smyth, J P Scott, L K Borysiewicz, et al.International Journal of Molecular Sciences|April 14, 2026
Correction: Vyas et al. Efficacy of Adeno-Associated Virus Serotype 9-Mediated Gene Therapy for AB-Variant GM2 Gangliosidosis. Int. J. Mol. Sci. 2023, 24, 14611Meera Vyas, Natalie M Deschenes, Karlaina J L Osmon, et al.Journal of Occupational and Environmental Medicine|May 9, 2014
Prevalence of undiagnosed cardiovascular risk factors and 10-year CVD risk in male steel industry workersBenjamin J Gray, Richard M Bracken, Daniel Turner, et al.Nature Protocols|January 27, 2017
Modeling and docking of antibody structures with RosettaBrian D Weitzner, Jeliazko R Jeliazkov, Sergey Lyskov, et al.Ebiomedicine|November 14, 2022
Long-term progression of retinal degeneration in a preclinical model of CLN7 Batten disease as a baseline for testing clinical therapeuticsAshley A Rowe, Xin Chen, Emily R Nettesheim, et al.Pageof 291